Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Boreal Genomics logo — company profile

Boreal Genomics

Founded 2007 Canada Canada 2 employees Secondary Market Total: $24.60M Biotechnology, Health Care

General Information

Company Name Boreal Genomics
Founded Year 2007
Location Canada Canada
Employees 2
Industries Biotechnology, Health Care
Funding Stage Secondary Market
Social

BounceWatch is an independent company data service, not affiliated with Boreal Genomics. To contact Boreal Genomics, visit borealgenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Boreal Genomics compare?

A PDF of Boreal Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Boreal Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Boreal Genomics

Boreal Genomics, founded in 2007, is a Canadian-based biotechnology startup with a focus on improving cancer patient care through the development of research tools and diagnostic tests. The company's OnTarget™ platform is designed to conduct highly sensitive mutation detection, enabling accurate tumor profiling and real-time monitoring of tumor evolution from cell-free DNA in plasma. As of the last investment on 01 March 2019, Boreal Genomics received a Secondary Market investment from Pender Technology Inflection Fund. Their innovative OnTarget™ assay is available as a research-use service, providing insights into tumor mutations that may be undetectable by other methods. This technology has the potential to guide therapy selection, improve clinical trial efficiency, and accelerate drug development programs within the biotechnology and healthcare industries.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Secondary Market Undisclosed 1
Pender Technology Inflection Fund
Pender Technology Inflection Fund
01 Mar 2019
Series C $18.00M 2
Arch Venture Partners Kearny Venture Partners
Arch Venture Partners, Kearny Venture Partners
04 Oct 2013
Series B $6.50M 2
In-Q-Tel GrowthWorks Capital
In-Q-Tel, GrowthWorks Capital
01 Oct 2010
Series A $100.00K -
01 Jan 2008

Boreal Genomics Alternatives & Competitors

View All Alternatives
Boreal Genomics vs
Biocept, Inc.
Biocept, Inc. United States

Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic...

Post-IPO Equity
49 employees
Biotechnology, Health Care
Boreal Genomics vs
Vortex Biosciences
Vortex Biosciences United States

Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have...

Venture round
7 employees
Biotechnology, Health Care
Boreal Genomics vs
Wren Laboratories
Wren Laboratories United States

Unleashing the Power of mRNA and AI for Cancer Diagnostics

25 employees
Biotechnology, Health Care
View all alternatives

FAQ About Boreal Genomics

At Boreal, we are committed to improving cancer patient care through development of research tools and diagnostic tests based on monitoring of circulating tumor DNA in plasma. Boreal’s OnTarget™ platform performs highly sensitive mutation detection to enable accurate tumor profiling and real-time...
Boreal Genomics was founded in 2007.
Boreal Genomics is headquartered in Canada.
Boreal Genomics operates in Biotechnology and Health Care.
Boreal Genomics has approximately 2 employees.
Boreal Genomics has completed 4 funding rounds, raising a total of $24.60M. The latest funding stage is Secondary Market.
Top alternatives and competitors to Boreal Genomics include Biocept, Inc. , Vortex Biosciences, Wren Laboratories, Nuclea Biotechnologies, Geneseeq Technology Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Boreal Genomics and Biocept, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Boreal Genomics, https://bouncewatch.com/company/boreal-genomics, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes